These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 26978860

  • 1. A Prospective, Randomized, Multicenter, Controlled Evaluation of the Use of Dehydrated Amniotic Membrane Allograft Compared to Standard of Care for the Closure of Chronic Diabetic Foot Ulcer.
    Snyder RJ, Shimozaki K, Tallis A, Kerzner M, Reyzelman A, Lintzeris D, Bell D, Rutan RL, Rosenblum B.
    Wounds; 2016 Mar; 28(3):70-7. PubMed ID: 26978860
    [Abstract] [Full Text] [Related]

  • 2. Treatment of diabetic foot ulcers with dehydrated amniotic membrane allograft: a prospective case series.
    Abdo RJ.
    J Wound Care; 2016 Jul 01; 25(Sup7):S4-S9. PubMed ID: 29027851
    [Abstract] [Full Text] [Related]

  • 3. Dehydrated Amnion Chorion Membrane versus standard of care for diabetic foot ulcers: a randomised controlled trial.
    Cazzell SM, Caporusso J, Vayser D, Davis RD, Alvarez OM, Sabolinski ML.
    J Wound Care; 2024 Jul 01; 33(Sup7):S4-S14. PubMed ID: 38973638
    [Abstract] [Full Text] [Related]

  • 4. A Retrospective Case Series of a Dehydrated Amniotic Membrane Allograft for Treatment of Unresolved Diabetic Foot Ulcers.
    Rosenblum BI.
    J Am Podiatr Med Assoc; 2016 Sep 02; 106(5):328-337. PubMed ID: 27439322
    [Abstract] [Full Text] [Related]

  • 5. The Comparative Effectiveness of a Human Fibroblast Dermal Substitute versus a Dehydrated Human Amnion/Chorion Membrane Allograft for the Treatment of Diabetic Foot Ulcers in a Real-world Setting.
    Kraus I, Sabolinski ML, Skornicki M, Parsons NB.
    Wounds; 2017 May 02; 29(5):125-132. PubMed ID: 28570252
    [Abstract] [Full Text] [Related]

  • 6. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR, Reyzelman A, Kawalec J, French M.
    Ostomy Wound Manage; 2017 Apr 02; 63(4):12-28. PubMed ID: 28448266
    [Abstract] [Full Text] [Related]

  • 7. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W, Cazzell S, Sigal F, Caporusso JM, Agnew PS, Hanft J, Dove C.
    Int Wound J; 2019 Feb 02; 16(1):122-130. PubMed ID: 30246926
    [Abstract] [Full Text] [Related]

  • 8. A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers.
    Zelen CM, Gould L, Serena TE, Carter MJ, Keller J, Li WW.
    Int Wound J; 2015 Dec 02; 12(6):724-32. PubMed ID: 25424146
    [Abstract] [Full Text] [Related]

  • 9. Topical Esmolol Hydrochloride as a Novel Treatment Modality for Diabetic Foot Ulcers: A Phase 3 Randomized Clinical Trial.
    Rastogi A, Kulkarni SA, Agarwal S, Akhtar M, Arsule S, Bhamre S, Bhosle D, Desai S, Deshmukh M, Giriraja KV, Jagannath J, Kashiva RY, Kesavan R, Khandelwal D, Kolte S, Kongara S, Darivemula AK, Madhusudan C, Pyare Saheb Qureshi MAH, Ramu M, Rathod G, Yalamanchi SR, Shakya S, Shetty P, Singh S, Deshpande SK, Viswanathan V, Unnikrishnan AG.
    JAMA Netw Open; 2023 May 01; 6(5):e2311509. PubMed ID: 37184839
    [Abstract] [Full Text] [Related]

  • 10. A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics.
    Tettelbach W, Cazzell S, Reyzelman AM, Sigal F, Caporusso JM, Agnew PS.
    Int Wound J; 2019 Feb 01; 16(1):19-29. PubMed ID: 30136445
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
    Frykberg RG, Cazzell SM, Arroyo-Rivera J, Tallis A, Reyzelman AM, Saba F, Warren L, Stouch BC, Gilbert TW.
    J Wound Care; 2016 Jul 01; 25(Sup7):S18-S25. PubMed ID: 29027848
    [Abstract] [Full Text] [Related]

  • 12. A clinical trial of Integra Template for diabetic foot ulcer treatment.
    Driver VR, Lavery LA, Reyzelman AM, Dutra TG, Dove CR, Kotsis SV, Kim HM, Chung KC.
    Wound Repair Regen; 2015 Jul 01; 23(6):891-900. PubMed ID: 26297933
    [Abstract] [Full Text] [Related]

  • 13. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
    Zelen CM, Orgill DP, Serena T, Galiano R, Carter MJ, DiDomenico LA, Keller J, Kaufman J, Li WW.
    Int Wound J; 2017 Apr 01; 14(2):307-315. PubMed ID: 27073000
    [Abstract] [Full Text] [Related]

  • 14. Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients.
    DiDomenico LA, Orgill DP, Galiano RD, Serena TE, Carter MJ, Kaufman JP, Young NJ, Jacobs AM, Zelen CM.
    Int Wound J; 2018 Dec 01; 15(6):950-957. PubMed ID: 30019528
    [Abstract] [Full Text] [Related]

  • 15. Evidence for Healing Diabetic Foot Ulcers With Biologic Skin Substitutes: A Systematic Review and Meta-Analysis.
    Gordon AJ, Alfonso AR, Nicholson J, Chiu ES.
    Ann Plast Surg; 2019 Oct 01; 83(4S Suppl 1):S31-S44. PubMed ID: 31513064
    [Abstract] [Full Text] [Related]

  • 16. Beta-adrenergic antagonist for the healing of chronic diabetic foot ulcers: study protocol for a prospective, randomized, double-blinded, controlled and parallel-group study.
    Kaur R, Tchanque-Fossuo C, West K, Hadian Y, Gallegos A, Yoon D, Ismailyan L, Schaefer S, Dahle SE, Isseroff RR.
    Trials; 2020 Jun 08; 21(1):496. PubMed ID: 32513257
    [Abstract] [Full Text] [Related]

  • 17. Multi-centre prospective randomised controlled clinical trial to evaluate a bioactive split thickness skin allograft vs standard of care in the treatment of diabetic foot ulcers.
    Armstrong DG, Galiano RD, Orgill DP, Glat PM, Carter MJ, Di Domenico LA, Reyzelman AM, Zelen CM.
    Int Wound J; 2022 May 08; 19(4):932-944. PubMed ID: 35080127
    [Abstract] [Full Text] [Related]

  • 18. Use of a dual-layer amniotic membrane in the treatment of diabetic foot ulcers: an observational study.
    Sledge I, Maislin D, Bernarducci D, Snyder R, Serena TE.
    J Wound Care; 2020 Sep 01; 29(Sup9):S8-S12. PubMed ID: 32924804
    [Abstract] [Full Text] [Related]

  • 19. A purified reconstituted bilayer matrix shows improved outcomes in treatment of non-healing diabetic foot ulcers when compared to the standard of care: Final results and analysis of a prospective, randomized, controlled, multi-centre clinical trial.
    Armstrong DG, Orgill DP, Galiano RD, Glat PM, Kaufman JP, Carter MJ, DiDomenico LA, Zelen CM.
    Int Wound J; 2024 Apr 01; 21(4):e14882. PubMed ID: 38606794
    [Abstract] [Full Text] [Related]

  • 20. Topical Erythropoietin Accelerates Wound Closure in Patients with Diabetic Foot Ulcers: A Prospective, Multicenter, Single-Blind, Randomized, Controlled Trial.
    Hamed S, Ullmann Y, Belokopytov M, Shoufani A, Kabha H, Masri S, Feldbrin Z, Kogan L, Kruchevsky D, Najjar R, Liu PY, Kerihuel JC, Akita S, Teot L.
    Rejuvenation Res; 2021 Aug 01; 24(4):251-261. PubMed ID: 33504262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.